KOREA EUNDAN CO., LTD. – Trademark Portfolio

Entity Type: 03

KOREA EUNDAN CO., LTD. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include EUNDAN. The owner is based in Gyeonggi-do.

100, Sagimakgol-ro

Jungwon-gu, Seongnam-si

Gyeonggi-do 13207 , KR

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EUNDAN
EUNDAN
Registered 2023
WITHBY
WITHBY
Cancelled 2018

Trademark Classifications

KOREA EUNDAN CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

40
Treatment & Processing (1 filing)

Treatment of materials

Frequently Asked Questions

How many trademarks does KOREA EUNDAN CO., LTD. have?

KOREA EUNDAN CO., LTD. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does KOREA EUNDAN CO., LTD. file in?

KOREA EUNDAN CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are KOREA EUNDAN CO., LTD.'s most well-known trademarks?

KOREA EUNDAN CO., LTD.'s registered trademark portfolio includes well-known marks such as EUNDAN. These are among 1 currently registered trademark in the portfolio.

What is KOREA EUNDAN CO., LTD.'s trademark registration success rate?

KOREA EUNDAN CO., LTD. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.